Lv5
1588 积分 2024-06-30 加入
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML
8天前
已完结
Dismantling relapsed/refractory mantle cell lymphoma
4个月前
已完结
Treatment of relapsed/refractory MCL
4个月前
已完结
Frontline management of mantle cell lymphoma
4个月前
已完结
Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study
4个月前
已完结
Long-term follow-up of the STOPAGO study
5个月前
已完结
STOP & GO: discontinuing TPO-RA in chronic ITP
5个月前
已完结
Oligoclonal Protein Bands and Ig Isotype Switching in Multiple Myeloma Treated With High-Dose Therapy and Hematopoietic Cell Transplantation
5个月前
已完结
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
6个月前
已完结
STOP & GO: discontinuing TPO-RA in chronic ITP
6个月前
已完结
皖公网安备34019202002308
